Laura Adriana de Rooij

Ms. Laura Adriana de Rooij

Pathology, UMC Utrecht, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2022 in Cancers
Verified
Journal Article
Open access
PDF file
LRLaura Adriana de Rooij
Laura Adriana de Rooij
DMDirk Jan Mastebroek
Dirk Jan Mastebroek
NVNicky ten Voorde
Nicky ten Voorde
EWElsken van der Wall
Elsken van der Wall
PDPaul J van Diest
Paul J van Diest
CMCathy Moelans
Cathy Moelans
MicroRNAs (miRNAs) are small non-coding RNAs of ~22 nucleotides that regulate gene expression at the post-transcriptional level. They can bind to around 60% of all protein-coding genes with an average of 200 targets per miRNA, indicating their important function within physiological and pathological cellular processes. miRNAs can be quickly produced in high amounts through canonical and non-canonical pathways that involve a multitude of steps and proteins. In cancer, miRNA biogenesis, availability and regulation of target expression can be altered to promote tumour progression. This can be due to genetic causes, such as single nucleotide polymorphisms, epigenetic changes, differences in host gene expression, or chromosomal remodelling. Alternatively, post-transcriptional changes in miRNA stability, and defective or absent components and mediators of the miRNA-induced silencing complex can lead to altered miRNA function. This review provides an overview of the current knowledge on the lifecycle of miRNAs in health and cancer. Understanding miRNA function and regulation is fundamental prior to potential future application of miRNAs as cancer biomarkers.